Tumor progression is associated with subversion of immunity, and signals in the tumor microenvironment originating from cancer cells, stroma, and other immunocompetent cells set tumor-associated macrophages to a tumor-promoting mode. Learn more:
New thesis on #Rhabdomyosarcoma from our partner group at #Oncobell - PI @omt2007. Congratulations, Dr Almacellas
Very happy to see the release of the three mTOR-related iBio videos we filmed over the summer. Was a real pleasure to work with such a professional team led by Karen Dell. mTOR and the Regulation of Growth • iBiology https://t.co/KWVOunJCaR
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766214.
Research Institute (IDIBELL)
Hospital Duran i Reynals, 3a planta
Gran Via de l’Hospitalet, 199
08908 L’Hospitalet del Llobregat